{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:52:45Z","timestamp":1790614365461,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.intimp.2023.109801","type":"journal-article","created":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T16:55:50Z","timestamp":1676134550000},"page":"109801","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["An oral NoV-rAd5 vaccine with built-in dsRNA adjuvant elicits systemic immune responses in mice"],"prefix":"10.1016","volume":"116","author":[{"given":"Jindong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongyao","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoman","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaojun","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.intimp.2023.109801_b0005","doi-asserted-by":"crossref","first-page":"e1001921","DOI":"10.1371\/journal.pmed.1001921","article-title":"World health organization estimates of the global and regional disease burden of 22 foodborne bacterial, protozoal, and viral diseases, 2010: a data synthesis","volume":"12","author":"Kirk","year":"2015","journal-title":"Plos. Med"},{"issue":"2","key":"10.1016\/j.intimp.2023.109801_b0010","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1099\/vir.0.059634-0","article-title":"Norovirus gene expression and replication","volume":"95","author":"Thorne","year":"2014","journal-title":"J. Gen. Virol"},{"issue":"7","key":"10.1016\/j.intimp.2023.109801_b0015","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3390\/vaccines9070732","article-title":"Advances in human norovirus vaccine research","volume":"9","author":"Zhang","year":"2021","journal-title":"Vaccines. (Basel)"},{"issue":"10","key":"10.1016\/j.intimp.2023.109801_b0020","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1099\/jgv.0.001318","article-title":"Updated classification of norovirus genogroups and genotypes","volume":"100","author":"Chhabra","year":"2019","journal-title":"J. Gen. Virol"},{"key":"10.1016\/j.intimp.2023.109801_b0025","doi-asserted-by":"crossref","unstructured":"M.C. Chan, S. Roy, J. Bonifacio, L.Y. Zhang, P. Chhabra, J. Chan, C. Celma, M.A. Igoy, S.L. Lau, K.N. Mohammad, J. Vinje, H. Vennema, J. Breuer, M. Koopmans, M. de Graaf, Detection of norovirus variant GII.4 Hong Kong in Asia and Europe, 2017-2019, Emerg Infect Dis 27(1) (2021)289-293.","DOI":"10.3201\/eid2701.203351"},{"key":"10.1016\/j.intimp.2023.109801_b0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01383","article-title":"Norovirus vaccine: priorities for future research and development","volume":"11","author":"Esposito","year":"2020","journal-title":"Front. Immunol"},{"key":"10.1016\/j.intimp.2023.109801_b0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.906275","article-title":"6-valent virus-like particle-based vaccine induced potent and sustained immunity against noroviruses in mice","volume":"13","author":"Hou","year":"2022","journal-title":"Front. Immunol"},{"issue":"13","key":"10.1016\/j.intimp.2023.109801_b0040","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.121077","article-title":"Safety and immunogenicity of an oral tablet norovirus vaccine, a phase I randomized, placebo-controlled trial","volume":"3","author":"Kim","year":"2018","journal-title":"JCI. Insight"},{"issue":"1","key":"10.1016\/j.intimp.2023.109801_b0045","doi-asserted-by":"crossref","DOI":"10.4110\/in.2021.21.e6","article-title":"Adenovirus vectors: excellent tools for vaccine development","volume":"21","author":"Chang","year":"2021","journal-title":"Immune. Netw"},{"issue":"20","key":"10.1016\/j.intimp.2023.109801_b0050","doi-asserted-by":"crossref","first-page":"11031","DOI":"10.1128\/JVI.00783-12","article-title":"Circumventing antivector immunity by using adenovirus-infected blood cells for repeated application of adenovirus-vectored vaccines: proof of concept in rhesus macaques","volume":"86","author":"Sun","year":"2012","journal-title":"J. Virol"},{"issue":"20","key":"10.1016\/j.intimp.2023.109801_b0055","doi-asserted-by":"crossref","first-page":"10780","DOI":"10.1128\/JVI.77.20.10780-10789.2003","article-title":"Oral vaccination of mice with adenoviral vectors is not impaired by preexisting immunity to the vaccine carrier","volume":"77","author":"Xiang","year":"2003","journal-title":"J. Virol"},{"issue":"4","key":"10.1016\/j.intimp.2023.109801_b0060","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/imm.12462","article-title":"Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of middle east respiratory syndrome coronavirus","volume":"145","author":"Guo","year":"2015","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.intimp.2023.109801_b0065","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/imr.13022","article-title":"The molecular mechanism of RIG-I activation and signaling","volume":"304","author":"Thoresen","year":"2021","journal-title":"Immunol. Rev"},{"issue":"17","key":"10.1016\/j.intimp.2023.109801_b0070","doi-asserted-by":"crossref","first-page":"8407","DOI":"10.1093\/nar\/gkw525","article-title":"Structural features of influenza a virus panhandle RNA enabling the activation of RIG-I independently of 5\u2032-triphosphate","volume":"44","author":"Lee","year":"2016","journal-title":"Nucleic. Acids. Res"},{"issue":"11","key":"10.1016\/j.intimp.2023.109801_b0075","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.imbio.2013.06.007","article-title":"Master sensors of pathogenic RNA-RIG-I like receptors","volume":"218","author":"Schlee","year":"2013","journal-title":"Immunobiology"},{"issue":"20","key":"10.1016\/j.intimp.2023.109801_b0080","doi-asserted-by":"crossref","first-page":"10612","DOI":"10.1128\/JVI.01526-15","article-title":"Enhanced influenza virus-like particle vaccination with a structurally optimized RIG-I agonist as adjuvant","volume":"89","author":"Beljanski","year":"2015","journal-title":"J. Virol"},{"issue":"3","key":"10.1016\/j.intimp.2023.109801_b0085","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1128\/JVI.02338-12","article-title":"A sendai virus-derived RNA agonist of RIG-I as a virus vaccine adjuvant","volume":"87","author":"Mart\u00ednez-Gil","year":"2013","journal-title":"J. Virol"},{"issue":"3","key":"10.1016\/j.intimp.2023.109801_b0090","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1128\/JVI.01250-10","article-title":"Coexpressed RIG-I agonist enhances humoral immune response to influenza virus DNA vaccine","volume":"85","author":"Luke","year":"2011","journal-title":"J. Virol"},{"issue":"6","key":"10.1016\/j.intimp.2023.109801_b0095","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1089\/hum.2018.258","article-title":"Single plasmid-based, upgradable, and backward-compatible adenoviral vector systems","volume":"30","author":"Liu","year":"2019","journal-title":"Hum. Gene. Ther"},{"issue":"8","key":"10.1016\/j.intimp.2023.109801_b0100","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.1128\/JVI.03114-13","article-title":"Inhibition of dengue and chikungunya virus infections by RIG-I-mediated type I interferon-independent stimulation of the innate antiviral response","volume":"88","author":"Olagnier","year":"2014","journal-title":"J. Virol"},{"key":"10.1016\/j.intimp.2023.109801_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2022.105214","article-title":"Identification of a novel norovirus species in fox","volume":"98","author":"Wang","year":"2022","journal-title":"Infection,. Genetics. Evolution"},{"issue":"2","key":"10.1016\/j.intimp.2023.109801_b0110","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/v11020091","article-title":"Immunological cross-reactivity of an ancestral and the most recent pandemic norovirus GII.4 variant","volume":"11","author":"Tamminen","year":"2019","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.intimp.2023.109801_b0115","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/v10010027","article-title":"Development of a surrogate neutralization assay for norovirus vaccine evaluation at the cellular level","volume":"10","author":"Wang","year":"2018","journal-title":"Viruses"},{"issue":"12","key":"10.1016\/j.intimp.2023.109801_b0120","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/j.vaccine.2006.11.044","article-title":"Intramuscular rather than oral administration of replication-defective adenoviral vaccine vector induces specific CD8+ T cell responses in the gut","volume":"25","author":"Lin","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.intimp.2023.109801_b0125","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1128\/CVI.00552-12","article-title":"An adenovirus-based vaccine with a double-stranded RNA adjuvant protects mice and ferrets against H5N1 avian influenza in oral delivery models","volume":"20","author":"Scallan","year":"2013","journal-title":"Clin. Vaccine. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2023.109801_b0130","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s40121-016-0108-z","article-title":"Oral modeling of an adenovirus-based quadrivalent influenza vaccine in ferrets and mice","volume":"5","author":"Scallan","year":"2016","journal-title":"Infect. Dis. Ther"},{"issue":"1","key":"10.1016\/j.intimp.2023.109801_b0135","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/infdis\/jiab561","article-title":"Oral vaccination protects against severe acute respiratory syndrome coronavirus 2 in a syrian hamster challenge model","volume":"225","author":"Johnson","year":"2022","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.intimp.2023.109801_b0140","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41423-020-00602-7","article-title":"Regulation of RIG-I-like receptor-mediated signaling: interaction between host and viral factors","volume":"18","author":"Onomoto","year":"2021","journal-title":"Cell. Mol. Immunol"},{"key":"10.1016\/j.intimp.2023.109801_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104877","article-title":"Murine norovirus replicase augments RIG-I-like receptors-mediated antiviral interferon response","volume":"182","author":"Yu","year":"2020","journal-title":"Antiviral. Res"},{"issue":"7","key":"10.1016\/j.intimp.2023.109801_b0150","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/biot.201400744","article-title":"NF-kappaB, CRE and YY1 elements are key functional regulators of cmv promoter-driven transient gene expression in CHO cells","volume":"10","author":"Brown","year":"2015","journal-title":"Biotechnol. J"},{"issue":"4","key":"10.1016\/j.intimp.2023.109801_b0155","doi-asserted-by":"crossref","first-page":"27","DOI":"10.32607\/20758251-2014-6-4-27-39","article-title":"Regulation of the target protein (transgene) expression in the adenovirus vector using agonists of Toll-like receptors","volume":"6","author":"Bagaev","year":"2014","journal-title":"Acta. Naturae"},{"issue":"1","key":"10.1016\/j.intimp.2023.109801_b0160","doi-asserted-by":"crossref","first-page":"e0146010","DOI":"10.1371\/journal.pone.0146010","article-title":"Human circulating antibody-producing B cell as a predictive measure of mucosal immunity to poliovirus","volume":"11","author":"Dey","year":"2016","journal-title":"Plos. One"},{"issue":"8","key":"10.1016\/j.intimp.2023.109801_b0165","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1086\/656364","article-title":"Serological correlate of protection against norovirus-induced gastroenteritis","volume":"202","author":"Reeck","year":"2010","journal-title":"J. Infect. Dis"},{"issue":"4","key":"10.1016\/j.intimp.2023.109801_b0170","article-title":"Parenterally administered P24-VP8* nanoparticle vaccine conferred strong protection against rotavirus diarrhea and virus shedding in gnotobiotic pigs","volume":"7","author":"Ramesh","year":"2019","journal-title":"Vaccines. (Basel)"},{"issue":"5","key":"10.1016\/j.intimp.2023.109801_b0175","article-title":"The antigenic topology of norovirus as defined by B and T cell epitope mapping: implications for universal vaccines and therapeutics","volume":"11","author":"van Loben","year":"2019","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.intimp.2023.109801_b0180","doi-asserted-by":"crossref","first-page":"e1005334","DOI":"10.1371\/journal.ppat.1005334","article-title":"Correlates of protection against norovirus infection and disease-where are we now, where do we go?","volume":"12","author":"Ramani","year":"2016","journal-title":"Plos. Pathog"},{"issue":"9","key":"10.1016\/j.intimp.2023.109801_b0185","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1080\/21645515.2018.1472185","article-title":"More robust gut immune responses induced by combining intranasal and sublingual routes for prime-boost immunization","volume":"14","author":"Hwang","year":"2018","journal-title":"Hum. Vaccin. Immunother"},{"key":"10.1016\/j.intimp.2023.109801_b0190","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.clim.2018.09.009","article-title":"Norovirus-specific mucosal antibodies correlate to systemic antibodies and block norovirus virus-like particles binding to histo-blood group antigens","volume":"197","author":"Tamminen","year":"2018","journal-title":"Clin. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923001248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923001248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T12:22:20Z","timestamp":1719231740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923001248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":38,"alternative-id":["S1567576923001248"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109801","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An oral NoV-rAd5 vaccine with built-in dsRNA adjuvant elicits systemic immune responses in mice","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109801","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109801"}}